| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.098 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |